These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 8484481

  • 21. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma.
    Kojima H, Shiwa M, Kamide Y, Moriyama H.
    Acta Otolaryngol; 1994 Jul; 114(4):423-9. PubMed ID: 7976315
    [Abstract] [Full Text] [Related]

  • 22. [Expression of 4F2-activation antigen in middle ear cholesteatoma].
    Holly A, Bujía J, Sanchez-Madrid F.
    Laryngorhinootologie; 1993 Jul; 72(7):324-7. PubMed ID: 8369083
    [Abstract] [Full Text] [Related]

  • 23. Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor localization in the baboon (Papio anubis) oviduct during steroid treatment and the menstrual cycle.
    Schell DL, Mavrogianis PA, Fazleabas AT, Verhage HG.
    J Soc Gynecol Investig; 1994 Jul; 1(4):269-76. PubMed ID: 9419783
    [Abstract] [Full Text] [Related]

  • 24. Transforming growth factor-alpha (TGF-alpha) and epidermal growth factor-receptor (EGF-R) immunoreactivity in normal and pathologic brain.
    Ferrer I, Alcántara S, Ballabriga J, Olivé M, Blanco R, Rivera R, Carmona M, Berruezo M, Pitarch S, Planas AM.
    Prog Neurobiol; 1996 Jun; 49(2):99-123. PubMed ID: 8844822
    [Abstract] [Full Text] [Related]

  • 25. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study.
    Ergün S, Zheng X, Carlsöö B.
    Acta Otolaryngol; 1994 May; 114(3):295-302. PubMed ID: 7521107
    [Abstract] [Full Text] [Related]

  • 26. [New concepts of the course of cholesteatoma from the immunohistological study of 96 samples].
    Mayot D, Bene MC, Perrin C, Faure GC, Wayoff M.
    Ann Otolaryngol Chir Cervicofac; 1991 May; 108(7):382-8. PubMed ID: 1789609
    [Abstract] [Full Text] [Related]

  • 27. A comparative immunohistochemical study of cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma, and in epidermis.
    Broekaert D, Cornille A, Eto H, Leigh I, Ramaekers F, Van Muijen G, Coucke P, De Bersaques J, Kluyskens P, Gillis E.
    Virchows Arch A Pathol Anat Histopathol; 1988 May; 413(1):39-51. PubMed ID: 2453971
    [Abstract] [Full Text] [Related]

  • 28. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma.
    Sudhoff H, Dazert S, Gonzales AM, Borkowski G, Park SY, Baird A, Hildmann H, Ryan AF.
    Am J Otol; 2000 Nov; 21(6):793-8. PubMed ID: 11078065
    [Abstract] [Full Text] [Related]

  • 29. Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.
    Haugen DR, Akslen LA, Varhaug JE, Lillehaug JR.
    Int J Cancer; 1993 Aug 19; 55(1):37-43. PubMed ID: 8102129
    [Abstract] [Full Text] [Related]

  • 30. Epidermal growth factor expression in middle ear cholesteatoma.
    Chi HP, Ho KY, Chai CY, Ta CF, Wang LF, Lee KW, Kuo WR, Wu SC, Tsai SM.
    Kaohsiung J Med Sci; 2004 Jan 19; 20(1):6-11. PubMed ID: 15481560
    [Abstract] [Full Text] [Related]

  • 31. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
    Broekaert D, Coucke P, Leperque S, Ramaekers F, Van Muijen G, Boedts D, Leigh I, Lane B.
    Ann Otol Rhinol Laryngol; 1992 Nov 19; 101(11):931-8. PubMed ID: 1280020
    [Abstract] [Full Text] [Related]

  • 32. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis.
    Van Blitterswijk CA, Grote JJ, Lutgert RW, Hesseling SC, Out CJ, Van Muijen GN, Fransen JA.
    Ann Otol Rhinol Laryngol; 1989 Aug 19; 98(8 Pt 1):635-40. PubMed ID: 2475048
    [Abstract] [Full Text] [Related]

  • 33. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
    Bujia J, Holly A, Sudhoff H, Antoli-Candela F, Tapia MG, Kastenbauer E.
    ORL J Otorhinolaryngol Relat Spec; 1996 Aug 19; 58(1):23-6. PubMed ID: 8718533
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Lymphotoxin in human middle ear cholesteatoma.
    Yan SD, Huang CC.
    Laryngoscope; 1991 Apr 19; 101(4 Pt 1):411-5. PubMed ID: 1680210
    [Abstract] [Full Text] [Related]

  • 36. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
    Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD, Tweardy DJ.
    J Natl Cancer Inst; 1998 Jun 03; 90(11):824-32. PubMed ID: 9625170
    [Abstract] [Full Text] [Related]

  • 37. Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy.
    Patel B, Hiscott P, Charteris D, Mather J, McLeod D, Boulton M.
    Br J Ophthalmol; 1994 Sep 03; 78(9):714-8. PubMed ID: 7947554
    [Abstract] [Full Text] [Related]

  • 38. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.
    Sasaki H, Huang CC.
    Otolaryngol Head Neck Surg; 1994 Mar 03; 110(3):310-7. PubMed ID: 7510866
    [Abstract] [Full Text] [Related]

  • 39. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
    Xie S, Wang X, Ren H, Liu X, Ren J, Liu W.
    Acta Otolaryngol; 2017 Aug 03; 137(8):797-802. PubMed ID: 28498080
    [Abstract] [Full Text] [Related]

  • 40. Induction of matrix metalloproteinases in keratinocytes by cholesteatoma debris and granulation tissue extracts.
    Schmidt M, Grünsfelder P, Hoppe F.
    Eur Arch Otorhinolaryngol; 2000 Aug 03; 257(8):425-9. PubMed ID: 11073191
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.